Congress Directs Federal Agencies to Review State Marijuana Laws and Diversion Prevention

A pivotal directive from the House Appropriations Committee is set to require federal agencies to evaluate the effectiveness of state marijuana regulations and assess strategies to prevent the diversion of legal cannabis into states where it remains prohibited. The committee will attach this instruction to the Fiscal Year 2027 Financial Services and General Government (FSGG) spending bill, marking a renewed push for federal oversight as the patchwork of state cannabis laws continues to expand

The proposed language calls on the Treasury Department’s Alcohol and Tobacco Tax and Trade Bureau (TTB), working alongside other agencies, to "coordinate an assessment of the adequacy of State marijuana regulatory frameworks, including commonalities and novel approaches to enforcement and oversight." This assessment aims not only to review current laws but also to generate recommendations for improving data sharing and coordination between state and federal authorities. The committee expects a briefing on these findings within one year of the bill’s enactment

This year’s report introduces a new provision urging the Department of Justice (DOJ), TTB, and additional agencies to examine the most effective methods for stopping legal cannabis from being diverted into prohibition states. "The Committee urges DOJ, in coordination with the broader Department, TTB, and other agencies that may have relevant regulatory expertise, to coordinate an assessment of the most effective methods of preventing diversion of state legal cannabis product into jurisdictions that do not permit the use of cannabis," the directive states

While similar cannabis-related provisions have appeared in previous appropriations cycles, it remains unclear whether the TTB has ever submitted a comprehensive marijuana policy report to lawmakers. The current directive echoes legislative efforts by House FSGG Appropriations Subcommittee Chairman Dave Joyce (R-OH), a leading advocate for cannabis reform, whose bill would create a federal commission to recommend a regulatory system for cannabis

Despite these steps toward federal engagement, the FSGG bill maintains the longstanding budget rider that blocks Washington, D.C. from legalizing and regulating adult-use marijuana sales. Local officials have worked around this constraint by expanding access to the medical cannabis program, but advocates see the provision—championed by Rep. Andy Harris (R-MD)—as a significant barrier to D.C. autonomy. The White House and previous presidential budgets have supported continuing this restriction, highlighting ongoing federal resistance to full legalization in the nation’s capital

From the OG Lab newsroom perspective, this directive signals a growing willingness in Congress to scrutinize and potentially harmonize state and federal cannabis regulations, especially as legalization spreads. However, the persistence of federal barriers in D.C. and uncertainty about agency follow-through underscore the complexities of national cannabis reform. Industry stakeholders should watch closely for the results of these assessments, as they could shape future federal policy and enforcement priorities